Latest Content

FDA grants priority review to Takeda’s orexin agonist oveporexton, promising phase 3 gains in wakefulness and cataplexy for narcolepsy type 1.

A rare psychiatrist-publisher dies at 97; explore Jason Aronson’s publishing legacy, Jewish studies ties, and free classic psychotherapy downloads.

Explore how AI transforms healthcare by enhancing diagnostics, personalizing treatments, and improving access while addressing significant risks and limitations.

Antidepressant withdrawal often mimics relapse; learn why hyperbolic tapering, informed consent, and slow cut-and-hold deprescribing reduce harm.

Inside the opioid epidemic: psychiatry and addiction care, MOUD options, and why stigma, policy, and jails still block lifesaving treatment.

In this Oscar-nominated film, a therapist mother spirals amid a child’s feeding disorder, exposing burnout and substance use.

This tribute to Rose Childs explores pioneering community mental health teamwork, cultural psychiatry innovation, shared leadership, and her lasting legacy in patient-centered care.

Heinrichs' POP model reaffirms the role of clinical judgment and patient-centered care.

Remembering Elise Snyder, MD, 91, who pioneered CAPA and video-based psychoanalytic training that bridged US-China mental health stigma and culture.

John J. Miller, MD, weighs in on APA's plans for the DSM and why global integration with the ICD should shape psychiatry’s future.

Cognition extends zervimesine expanded access for Lewy body dementia, adding months of dosing and easier local monitoring.

Long-term antidepressant use rises in Australia, surging among individuals aged 10 to 24, with more off-label sleep and pain prescribing raising safety and withdrawal concerns.

Congress backs printing 988 on student ID cards, boosting youth crisis access and funding.